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Abstract
Introduction:  Health-related  quality  of  life  (HRQoL)  is  used  to  denote  that  portion  of  the  quality
of life  that  is  inﬂuenced  by  the  person’s  health.
Objectives:  To  compare  the  HRQoL  of  individuals  with  vestibular  disorders  of  peripheral  ori-
gin by  analyzing  functional,  emotional  and  physical  disabilities  before  and  after  vestibular
treatment.
Methods: A  prospective,  non  randomized  case-controlled  study  was  conduced  in  the  ENT
Department,  between  January  2015  and  December  2015.  All  patients  were  submitted  to  cus-
tomize a  36  item  of  health  survey  on  quality  of  life,  short  form  36  health  survey  questionnaire
(SF-36) and  the  Dizziness  Handicap  Inventory  (DHI)  for  assessing  the  disability.  Individuals  were
diagnosed with  acute  unilateral  vestibular  peripheral  disorders  classiﬁed  in  5  groups:  vestibular
neuritis, Ménière  Disease  (MD),  Benign  Paroxysmal  Positional  Vertigo  (BPPV),  cochlear-vestibular
dysfunction  (other  than  MD),  or  other  type  of  acute  peripheral  vertigo  (as  vestibular  migraine).
Results:  There  was  a  statistical  signiﬁcant  difference  for  each  parameter  of  DHI  score  (the
emotional, functional  and  physical)  between  the  baseline  and  one  month  both  in  men  and
women, but  with  any  statistical  signiﬁcant  difference  between  7  days  and  14  days.  It  was
found a  statistical  signiﬁcant  difference  for  all  eight  parameters  of  SF-36  score  between  the
baseline  and  one  month  later  both  in  men  and  women;  the  exception  was  the  men  mental
health perception.  The  correlation  between  DHI  and  SF-36  scores  according  to  diagnostics  type
pointed out  that  the  Spearman’s  correlation  coefﬁcient  was  moderate  correlated  with  the  total
scores of  these  instruments. Please cite this article as: Petri M, Chirila˘ M, Bolboaca˘ SD, Cosgarea M. Health-related quality of life and disability in patients with acute
unilateral peripheral vestibular disorders. Braz J Otorhinolaryngol. 2016. http://dx.doi.org/10.1016/j.bjorl.2016.08.004
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Conclusion:  The  DHI  and  the  SF-36  are  useful,  proved  practical  and  valid  instruments  for
assessing the  impact  of  dizziness  on  the  quality  of  life  of  patients  with  unilateral  peripheral
vestibular  disorders.
©  2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/4.0/).
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Qualidade  de  vida  relacionada  à  saúde  e  incapacidade  em  pacientes  com  distúrbios
vestibulares  periféricos  unilaterais  agudos
Resumo
Introduc¸ão:  Qualidade  de  Vida  relacionados  à  saúde  (QVRS)  é  utilizada  para  designar  a  parte
da qualidade  de  vida  que  é  inﬂuenciada  pela  saúde  do  indivíduo.
Objetivos:  Comparar  a  QVRS  de  indivíduos  com  distúrbios  vestibulares  de  origem  periférica,
analisando  incapacidades  funcionais,  emocionais  e  físicas  antes  e  após  o  tratamento  vestibular.
Método: Um  estudo  de  caso-controle  prospectivo,  não  randomizado  foi  conduzido  no  Departa-
mento de  Otorrinolaringologia,  entre  janeiro  de  2015  e  dezembro  de  2015.  Todos  os  pacientes
foram submetidos  a  uma  pesquisa  de  saúde  personalizada  de  36  itens  sobre  qualidade  de  vida,  ao
formulário abreviado  de  avaliac¸ão  de  saúde  36  (SF-36)  e  ao  Dizziness  Handicap  Inventory  (DHI)
para avaliar  a  incapacidade.  Os  indivíduos  foram  diagnosticados  com  distúrbios  vestibulares
periféricos  unilaterais  agudos,  classiﬁcados  em  5  grupos:  neurite  vestibular,  Doenc¸a  de  Ménière
(DM), vertigem  posicional  paroxística  benigna  (VPPB),  disfunc¸ão  cócleo-vestibular  (exceto  DM),
ou outro  tipo  de  vertigem  periférica  aguda  (como  enxaqueca  vestibular).
Resultados:  Houve  uma  diferenc¸a  estatisticamente  signiﬁcante  para  cada  parâmetro  de  escore
no DHI  (emocional,  funcional  e  físico)  entre  a  avaliac¸ão  basal  e  depois  de  um  mês,  tanto  em
homens quanto  em  mulheres,  mas  sem  diferenc¸a  estatística  signiﬁcativa  entre  7  dias  e  14  dias.
Foi encontrada  uma  diferenc¸a  estatisticamente  signiﬁcante  para  todos  os  oito  parâmetros  do
escore no  SF-36  entre  a  avaliac¸ão  basal  e  um  mês  mais  tarde,  tanto  em  homens  quanto  em
mulheres;  a  excec¸ão  foi  a  percepc¸ão  de  saúde  mental  nos  homens.  A  correlac¸ão  entre  DHI  e  o
SF-36 de  acordo  com  o  tipo  de  diagnóstico  mostrou  que  o  coeﬁciente  de  correlac¸ão  de  Spearman
foi moderado  quando  correlacionado  com  o  escore  total  desses  instrumentos.
Conclusão:  O  DHI  e  o  SF-36  demonstraram  ser  instrumentos  úteis,  práticos  e  válidos  para  avaliar
o impacto  da  tontura  na  qualidade  de  vida  de  pacientes  com  distúrbios  vestibulares  periféricos
unilaterais.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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uality  of  life  is  deﬁned  as  an  individual  perception  of
er/his  position  in  life  in  the  context  of  the  culture  and
alue  systems  in  which  she/he  lives,  and  it  encompasses
 broad  spectrum  of  domains  including  health  status,  eco-
omic  resources,  work  status,  relationships,  and  leisure
ctivities.1 Health-Related  Quality  of  Life  (HRQoL)  is  used  to
enote  that  portion  of  the  quality  of  life  that  is  inﬂuenced
y  the  person’s  health.
Vertigo  or  dizziness  is  one  of  the  most  common  condi-
ions  that  brings  patients  to  emergency  and  its  incidence
ncreases  with  age.2 Despite  a  lifetime  prevalence  of  dizzi-
ess  and  vertigo  estimated  at  20--30%  and  1-year  prevalence
stimate  for  vertigo  of  4.9%,  the  healthcare  burden  of
ertigo  is  still  relatively  under-reported  due  to  the  unpre-
ictability  of  attacks  and  the  nature  of  the  disease.3
n  individual’s  progress  or  lack  of  progress  in  vestibular
(
l
wehabilitation  is  usually  measured  by  observing  changes  in
otion  intolerance,  balance,  functional  abilities  and  more
ecently,  health-related  quality  of  life.4 Currently  avail-
ble  conventional  diagnostic  tests  (i.e.  bed-side  vestibular
xamination,  videonystagmography,  caloric  and  rotational
ests,  and  posturography)  are  inadequate  for  evaluating  the
ebilitating  effects  associated  with  vestibular  disorders.5
onsequently,  various  questionnaires  (such  as  General
epression  Scale,  Strait-Trait  Anxiety  Index,  Dynamic  Gait
ndex,  the  Functional  Gait  Assessment,  the  Balance  Error
coring  System)6 have  been  developed  in  an  attempt  to
uantify  the  self-perceived  health  status  in  vestibular
atients  with  dizziness  and  imbalance.
The  Dizziness  Handicap  Inventory16  (DHI)  and  the  Medi-
al  Outcomes  Study  (MOS)  36-Item  Short-Form  Health  Survey
SF-36)  are  two  commonly  used  health-related  quality-of
ife  survey  instruments.  The  SF-36  is  a  generic  questionnaire
ith  a global  approach  to  measure  health  status  as  it  relates
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HRQoL  and  unilateral  peripheral  vestibular  disorders  
to  an  individual’s  functional  well-being;  it  has  been  widely
used  in  studies  of  the  outcome  for  chronic  diseases,  and  it
facilitates  comparison  of  the  clinical  health  of  patients  with
the  average  standardized  scores  of  the  general  population.7
The  Dizziness  Handicap  Inventory  (DHI),  a  disease-speciﬁc
questionnaire,  was  developed  for  individuals  with  dizziness
or  balance  problems  and  measures  how  vertigo  and  disequi-
librium  (imbalance)  affect  an  individual’s  quality  of  life;
this  is  a  25  item  scale  that  was  designed  to  evaluate  the
effect  of  dizziness  and  unsteadiness  on  the  functional,  emo-
tional,  and  physical  aspects  of  everyday  life.8 The  ability
to  detect  the  minimal  clinical  change  in  a  variable  over
time  is  responsiveness;  the  DHI  and  the  SF-36  provide  the
opportunity  to  compare  the  responsiveness  of  these  two
measurement  instruments  in  HRQoL  of  patients  with  ves-
tibular  dysfunctioning.9
The  aim  of  this  study  was  to  determinate  the  relation-
ship  between  disability  and  HRQoL  in  patients  with  acute
unilateral  vertigo  of  peripheral  origin  by  analyzing  func-
tional,  emotional,  and  physical  disabilities  before  and  after
vestibular  treatment.
Methods
A  prospective,  non  randomized  study  was  conducted  on  indi-
viduals  diagnosed  with  acute  unilateral  vestibular  peripheral
disorders.  All  patients  were  submitted  to  customize  a  36
item  of  health  survey  on  quality  of  life,  short  form  36
health  survey  questionnaire  (SF-36)  and  the  Dizziness  Hand-
icap  Inventory  (DHI)  for  assessing  the  disability.  All  patients
answered  the  SF-36  and  DHI  both  at  the  beginning  and  the
end  of  the  follow  up  (SF-36:  baseline  &  1  month  follow-up;
DHI:  baseline,  7  days,  14  days  and  1  month  follow-up).  The
study  was  approved  by  the  Ethics  Committee  of  University
of  Medicine  and  Pharmacy  (Reference  n◦ 200/8.05.2015).
The  unilateral  vestibular  peripheral  disorders  were  classi-
ﬁed  by  type  of  peripheral  vestibular  disturbance  in  5  groups:
vestibular  neuritis,  Ménière  disease,  Benign  Paroxysmal
Positional  Vertigo  (BPPV),  cochlear-vestibular  dysfunction
(other  than  Ménière  disease),  or  other  type  of  acute  periph-
eral  vertigo  (as  vestibular  migraine).
Vestibular  neuritis  was  diagnosed  as  an  acute,  sustained
dysfunction  of  unilateral  peripheral  vestibular  system  with
secondary  nausea,  vomiting,  vertigo,  and  preserved  audi-
tory  function.  Symptoms  typically  started  with  a  sudden
attack  of  vertigo  (a  sensation  of  swaying  or  spinning)  or  dizzi-
ness,  often  accompanied  by  difﬁculty  with  vision  or  balance
and  could  range  from  mild  dizziness  to  a  violent  spinning
or  swaying  sensation.  The  most  severe  symptoms  generally
lasted  for  a  matter  of  days.  Less-severe  symptoms  gradually
diminished  over  several  weeks,  and  some  people  recovered
completely.
A  typical  attack  of  Meniere’s  disease  was  preceded  by
fullness  in  one  ear;  rarely  occurred  hearing  ﬂuctuation  or
changes  in  tinnitus.  A  Meniere’s  episode  or  ‘‘attack’’  gener-
ally  involved  severe  vertigo  (spinning),  imbalance,  nausea
and  vomiting  as  well  as  acute  reduction  of  hearing.  The
average  attack  lasted  two  to  four  hours.
BPPV  included  dizziness  or  vertigo,  lightheadedness,
imbalance,  and  nausea.  Activities  which  bring  on  symptoms
will  vary  among  persons,  but  in  our  patients  symptoms  were
i
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lmost  always  precipitated  by  a  change  of  position  of  the
ead  with  respect  to  gravity.
Cochlear-vestibular  dysfunction  included  patients  with
cute  vertigo  of  peripheral  origin  associated  hearing  loss
r  acute  tinnitus  who  were  not  eligible  for  Meniere  disease
roup.
Other  type  of  acute  peripheral  vertigo  refers  to  vertigo
ssociated  migraine.  The  clinical  presentation  of  vesti-
ular  symptoms  that  often  correlate  with  migraine  included:
izziness;  motion  intolerance  with  respect  to  head,  eyes,
nd/or  body;  spontaneous  vertigo  attacks  (often  accompa-
ied  by  nausea  and  vomiting);  diminished  eye  focus  with
hotosensitivity;  sound  sensitivity  and  tinnitus;  balance  loss
nd  ataxia;  cervicalgia  (neck  pain)  with  associated  muscle
pasms  in  the  upper  cervical  spine  musculature;  confusion
ith  altered  cognition;  spatial  disorientation;  and  anxi-
ty/panic.
These  subjects  attended  the  ENT  Department,  Emer-
ency  County  Hospital,  between  January  2015  and  Decem-
er  2015.  The  patients  signed  an  informed  consent  form
nd  accepted  both  the  participation  and  the  follow-up
chedule  prior  to  enrolment.  All  the  patients  were  submit-
ed  to  a  complete  ENT  evaluation  and  complete  medical
istory,  neurological  examination,  otological  and  audiolog-
cal  assessment  with  impedance  measures  and  auditory
voked  potentials,  vestibular  tests,  including  videonystag-
ography,  caloric  tests,  computer  tomography  or  magnetic
esonance  imaging  as  appropriate.  There  were  excluded:
ndividuals  who  presented  central  vestibular  alterations;
‘dizziness’’  without  a  diagnosis  of  acute  unilateral  periph-
ral  vestibular  disorder;  people  with  clinical  diagnosis
f  neurological  degenerative  diseases  and/or  cerebellar
isease  or  posttraumatic  vertigo;  patients  received  prior
estibular  rehabilitation  or  currently  receiving  vestibular
ehabilitation,  or  using  antivertiginous  medication  before
resentation.  Information  was  collected  as  demographic
haracteristics  (age,  gender,  origin)  and  clinical  data  (type
f  peripheral  vestibular  disorder:  BPPV,  Ménière,  other
ochlear-vestibular  dysfunction,  vestibular  neuritis,  and
ther  types  of  acute  peripheral  vertigo),  use  of  medication
yes  or  no)  and  associated  comorbidities.
The  Short-Form  Health  Survey  (SF-36)  is  a validated
hort-form  health  questionnaire  composed  of  36  items.10
F-36  measures  health  on  eight  multi-item  dimensions,
overing  functional  status,  well  being,  and  overall  evalua-
ion  of  health:  functional  status  with  physical  functioning
10  items),  social  functioning  (2  items),  role  limitations
physical  problems)  (4  items),  role  limitations  (emotional
roblems)  (3  items),  wellbeing  with  mental  health  (5  items),
itality  (4  items),  pain  (2  items)  and  overall  evaluation  of
ealth  with  general  health  perception  (6  items).  For  each
ariable,  item  scores  are  coded,  summed,  and  transformed
n  a scale  from  0  (worst  possible  health  state  measured  by
he  questionnaire)  to  100  (best  possible  health  state).  It  is
 generic  health  measure,  rather  than  disease-speciﬁc.
DHI  was  developed  by  Jacobson  et  al.  in  19906 a tool  used
o  quantify  the  impact  of  vertigo  in  daily  life  activities  and
ituations.  The  Dizziness  Handicap  Inventory  (DHI)  is  a  val-
dated  25  item,  self-perceived  handicap  scale  designed  to
ssess  the  effect  of  dizziness  and  unsteadiness  on  quality
f  life.10 The  items  are  grouped  into  3  subscales  evaluat-
ng  the  effects  of  dizziness  and  unsteadiness  on  emotional,
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aigure  1  Disability  function  of  the  acute  unilateral  vestibular
isorder  according  to  gender.
unctional,  and  physical  aspects  of  daily  living.  For  each
tem,  there  are  3  possible  answers:  no,  sometimes,  and  yes,
iving,  respectively,  0,  2,  and  4  points.  There  are  seven  ques-
ions  assessing  physical  aspects,  nine  assessing  emotional
ssues  and  nine  evaluating  functional  issues.  A  total  score  of
00  corresponds  to  the  worst  self-perceived  disability  hand-
cap,  and  a  total  score  of  0  to  the  absence  of  handicap.  As
t  might  not  be  adequate  to  use  the  3  subscales  separately,
nly  the  total  DHI  score  was  used  for  interpretation.  The
uestionnaires  were  submitted  to  patients  during  an  inter-
iew  at  the  ENT  department  and  the  data  were  collected  for
alculating  the  disability  in  function  of  the  acute  unilateral
estibular  disorder  according  to  gender  (Fig.  1).
All  statistical  tests  were  performed  with  Statistica  soft-
are,  version  8.0  (StatSoft,  Inc.  2300  East  14th  Street,  Tulsa,
K  74104).  Categorical  variables  were  summarized  with
[
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ercentage  and  associated  95%  Conﬁdence  Intervals  com-
uted  using  an  exact  formula.11 Group  percentages  were
ompared  with  the  use  of  Z  test  for  proportions.  Numeri-
al  variables  were  summarized  as  mean  ±  standard  deviation
henever  data  proved  to  follow  normal  distribution  and
edian  and  IRQ  (Q1--Q3),  where  Q1  =  25th  percentile,
3  =  75th  percentile)  otherwise.  Two  group  means  for  normal
ariables  and  non-normal  distribution  were  compared  with
he  used  of  Student  t-test  for  independent  groups,  paired
tudent  t-test,  and  the  Mann--Whitney  U-test,  respectively.
riedman  ANOVA  test  was  applied  to  compare  longitudinal
umerical  data  non-normal  distributed  on  dependent  sam-
les.  Two-tailed  p-value  less  than  0.05  indicated  statistical
igniﬁcance.
esults
ne  hundred  subjects  completed  the  study  (baseline
nd  follow-up  evaluations),  with  signiﬁcant  higher  num-
er  of  women  compared  to  men  (72%  [62.01--80.99]
s.  28%  [19.01--37.99];  Z-statistic  =  −9.80,  p  <  0.0001).
he  age  of  patients  ranged  from  28  to  71  years
ld  (47.78  ±  14.74  years),  without  a  signiﬁcant  differ-
nce  (t-statistic  =  −0.6501,  p  =  0.5172)  between  women
47.18  ±  14.91)  and  men  (49.32  ±  14.46).  For  both  genders,
he  majority  of  patients  were  aged  51--60  years  old  (29.17%
19.46--41.65]  women  vs.  39.29%  men  [21.56--60.59]),  then
1--40  years  old  (20.83%  [12.52--31.92]  women  vs.  25.00%
en  [10.84--46.3]).  A signiﬁcant  (Z-statistic  = −12.83,
 < 0.0001)  higher  percent  of  patients  were  from  urban
reas  (77%  [68.01--84.99])  compared  to  rural  areas  (23%
15.01--31.99]).
On  both  genders,  the  most  frequent  diagnosis  was  vesti-
ular  neuritis.  A  signiﬁcant  higher  percent  of  women  were
iagnosed  with  Ménière  disease  compared  to  men  (11.11%
Benign paroxysmal positional vertigo (BPPV)
eripheral vertigo
22.22 0.00 30.43
75.00 43.48
26.0925.0033.33
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17.39
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g  with  DHI  and  diagnosis.
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Table  1  DHI  scores  at  the  baseline,  7  and  14  days,  and  1  month.
Domain  Women  Men  Mann--Whitney  (p-value)
Emotional
Baseline  13  (6--20)  15  (6--22)  1.15  (0.2481)
7 days  10  (4--18)  11  (4--18)  1.07  (0.2824)
14 days  6  (0--10)  8  (2--12.5)  0.66  (0.5061)
1 month  2  (0--4)  5  (2--8.5)  0.77  (0.4439)
Friedman  ANOVA
(p-value)
183.83  (<0.0001)  65.53  (<0.0001)
Kendall Concordance  0.849  0.772
Functional
Baseline  22  (14--28) 21  (16--29) 1.16  (0.2452)
7 days 17  (10--24) 18  (15--26) 1.61  (0.1083)
14 days  8  (4--12)  11  (7.5--17)  1.80  (0.0714)
1 month  4  (2--8)  8  (4--12.5)  0.98  (0.3267)
Friedman  ANOVA
(p-value)
205.44  (<0.0001)  73.96  (<0.0001)
Kendall Concordance 0.9504 0.8671
Physical
Baseline  18  (12--22.5)  17  (12--22.5)  1.05  (0.2959)
7 days  14  (8--20)  14  (9.5--18.5)  1.33  (0.1849)
14 days  6  (4--10)  8  (3.5--12)  0.79  (0.4278)
1 month  2  (0--4)  4  (2--8)  −0.49  (0.6213)
Friedman  ANOVA
(p-value)
203.03  (<0.0001)  69.61  (<0.0001)
Kendall Concordance  0.9391  0.8223
Total
Baseline  51  (35.5--70)  47  (39--70)  1.26  (0.2064)
7 days  42  (26--58.5)  43  (29.5--59)  1.68  (0.0938)
14 days  22  (10--32)  24  (17.5--42)  1.47  (0.1410)
1 month  10  (4--18.5)  17  (10--27)  0.54  (0.5899)
Friedman  ANOVA
(p-value)
210.92  (<0.0001)  77.03  (<0.0001)
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vs.  3.57%;  Z-statistic  =  −2.40,  p  =  0.0164),  without  other  sig-
niﬁcant  differences  between  genders  (p  >  0.05).
Classiﬁcation  of  the  handicap  according  with  DHI  and
diagnosis  over  the  time  is  presented  in  Fig.  2.
Within  each  DHI  domains  of  dizziness,  signiﬁcant  differ-
ences  have  been  observed  between  pairs  of  investigated
domains  on  both  women  and  men  (see  Friedman  ANOVA  in
Table  1,  p  <  0.0001).  There  was  a  statistical  signiﬁcant  dif-
ference  for  each  parameter  of  DHI  score  (the  emotional,
functional  and  physical)  between  the  baseline  and  one
month  (Table  1)  both  in  men  and  women,  but  with  any  sta-
tistical  signiﬁcant  difference  between  7  days  and  14  days.
Within  each  SF-36  domains,  signiﬁcant  differences  have
been  observed  between  pairs  of  investigated  domains  on
both  women  and  men,  unless  in  mental  health  at  one  month
in  men  (see  Mann--Whitney  test,  Paired  Student  t-test  in
Table  2,  p  <  0.0001).  It  was  found  a  statistical  signiﬁcant  dif-
ference  for  all  eight  parameters  of  SF-36  score  between  the
baseline  and  one  month  later  both  in  men  and  women;  the
exception  was  the  men  mental  health  perception  with  no
statistical  signiﬁcant  difference  between  the  baseline  and
one  month  later  (Student  t-test,  p  =  0.1966)  (Table  2).
t
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v
i0.914
The  functional,  emotional,  and  physical  pre-treatment
cores  were  signiﬁcantly  higher  in  patients  with  MD  than
n  patients  with  vestibular  neuritis  or  BPPV  (which  implies
hat  inconvenience  that  patients  with  MD  face  in  their  daily
ife  appears  to  be  the  greatest;  (Spearman  Rank  Correla-
ion,  p  <  0.05).  The  correlation  between  DHI  and  SF-36  scores
ccording  to  diagnostics  type  pointed  out  that  the  Spear-
an’s  correlation  coefﬁcient  was  moderate  correlated  with
he  total  scores  of  both  instruments.  The  negative  values
ndicate  score  inversions  in  the  answers  of  one  instrument
elative  to  the  other  (Table  3).
iscussion
he  objective  of  this  research  was  to  determine  the  rela-
ionship  between  disability  and  HRQoL  in  patients  with  acute
nilateral  vertigo  of  peripheral  origin  before  and  after  ves-
ibular  treatment.  Besides  the  correlation  obtained  in  the
ajority  of  the  responses  provided  by  participants,  the
ariables  of  both  questionnaires  showed  an  inverse  behav-
or:  higher  deterioration  in  the  quality  of  life  expressed  by
ARTICLE IN PRESS+Model
6  Petri  M  et  al.
Table  2  SF-36  scores  at  the  baseline  and  1  month.
Domain  All  Women  Men  p-value
Physical  Health-  Physical  Functioning  (PF)a
Baseline  550.0  (350.0--750.0)  550.0  (337.5--550.0)  625.0  (387.5--787.5)  −0.74  (0.4611)
1 month  900.0  (800.0--1000.0)  900.0  (800.0--900.0)  900.0  (700.0--962.5)  0.26  (0.7970)
Statistics (p-value)  9.70  (<0.0001)  8.19  (<0.0001)  5.00  (<0.0001)
Role-Physical  (RP)a
Baseline  0.0  (0.0--200.0)  0.0  (0.0--0.0)  0.0  (0.0--200.0)  0.10  (0.9205)
1 month  400.0  (400.0--400.0)  400.0  (400.0--400.0)  400.0  (75.0--400.0)  0.83  (0.4070)
Statistics (p-value)  7.88  (<0.0001)  6.72  (<0.0001)  3.88  (0.0001)
Bodily Pain  (BP)a
Baseline  90.0  (65.0--135.0) 90.0  (65.0--90.0)  112.5  (88.8--136.3)  −0.95  (0.3431)
1 month  140.0  (135.0--180.0)  140.0  (130.0--140.0)  155.0  (135.0--185.0)  −0.33  (0.7413)
Statistics (p-value)  9.06  (<0.0001)  7.75  (<0.0001)  4.51  (<0.0001)
General  Health  (GH)b
Baseline  276.00  ±  102.37  272.92  ±  105.13  283.93  ±  96.28  −0.48  (0.6315)
1 month 417.25  ±  65.20  414.93  ±  65.90  423.21  ±  64.16  −0.57  (0.5710)
Statistics (p-value) −17.08  (<0.0001) −13.76  (<0.0001)  −10.55  (<0.0001)
Mental Health  Vitality  (VT)a
Baseline  200.0  (120.0--245.0)  200.0  (140.0--200.0)  210.0  (120.0--245.0)  −0.02  (0.9816)
1 month  320.0  (280.0--340.0)  320.0  (280.0--320.0)  320.0  (280.0--345.0)  −0.45  (0.6561)
Statistics (p-value)  9.80  (<0.0001)  8.25  (<0.0001)  5.10  (<0.0001)
Role-Emotional  (RE)a
Baseline  0.0  (0.0--300.0)  0.0  (0.0--300.0)  100.0  (0.0--300.0)  −1.21  (0.2281)
1 month  300.0  (300.0--300.0)  300.0  (300.0--300.0)  300.0  (300.0--300.0)  −0.27  (0.7882)
Statistics (p-value)  7.08  (<0.0001)  6.18  (<0.0001)  3.18  (0.0015)
Social Functioning  (SF)a
Baseline  100.0  (75.0--125.0)  100.0  (75.0--100.0)  87.5  (75.0--162.5)  −0.40  (0.6897)
1 month  175.0  (150.0--200.0)  175.0  (150.0--175.0)  175.0  (150.0--200.0)  −1.17  (0.2417)
Statistics (p-value)  9.38  (<0.0001)  8.19  (<0.0001)  4.36  (<0.0001)
Mental Health  (MH)b
Baseline  341.20  ±  70.89  335.28  ±  73.50  356.43  ±  62.31  −1.35  (0.1817)
1 month  355.00  ±  66.14  350.83  ±  67.21  365.71  ±  63.21  −1.01  (0.3148)
Statistics (p-value)  −3.24  (0.0016)  −2.95  (0.0043)  −1.32  (0.1966)
a Median (interquartile range expressed as Q1--Q3), Sign test on row comparison between baseline and 1 month) & Mann--Whitney test
on the last column (comparisons between women and men).
b pariso
l
e
s
f
t
i
o
d
w
p
t
f
i
p
C
n
m
w
t
o
P
d
w
s
o
c
cMean ± standard deviation, Paired Student t-test on row (com
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ow  scores  was  correlated  with  higher  degree  of  disability
xpressed  by  high  scores,  and  vice  versa.
In  our  study  the  higher  improvement  in  total  DHI
core  and  SF-36  scales  at  one  month  after  treatment  was
or  patients  with  vestibular  neuritis  and  BPPV,  two  well-
reatable  conditions.  We  also  observed  a  good  quality
mprovement  of  DHI  total  score  for  Ménière  disease  after
ne  month  compared  with  other  cochlear-vestibular  syn-
romes  or  vestibular  migraine.  We  have  to  specify  that
e  performed  solumedrol  transtympanic  injections  for  all
atients  with  MD  with  very  good  results  on  acoustic  symp-
oms  and  good  for  vertigo;  another  possible  explanation
or  these  results  could  be  the  pathophysiology  of  MD  as
nner  ear  disease  is  much  conceivable  to  the  individual
atient  than  migraine  as  rather  complicated  brain  disorder.5
orrelations  between  internal  categories  of  both  question-
aires  used  in  our  study  shown  that  most  of  them  presented
i
p
pn between baseline and 1 month) & Independent Samples t-test
oderate  relationships.  The  three  scales  of  the  SF-36  that
ere  most  related  to  mental  health  had  correlations  with
he  DHI  emotional  score.
In  the  literature,  the  type  of  peripheral  vestibular  dis-
rder  that  occurs  more  frequently  is  benign  Paroxysmal
ositional  Vertigo  (BPPV).12 We  found  that  the  most  frequent
iagnosis  on  both  genders  was  vestibular  neuritis.
In  our  study,  72%  of  samples  were  women  that  coincide
ith  authors  that  had  described  the  prevalence  of  vestibular
ymptoms  in  women  for  several  reasons  such  as  menopause,
steoporosis,  cardio-vascular  and  metabolic  diseases,  which
ause  symptoms  of  dizziness.13 However,  Obermann  et  al.5
onsidered  that  selection  bias  of  older  women  may  have
nﬂuenced  the  study  results  and,  consequently,  the  inter-
retation.
Like  in  our  case-controlled  study,  the  samples  used  in
revious  studies  also  differed  in  the  etiology  of  dizziness
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Table  3  Correlations  between  DHI  and  SF-36  scores  accord-
ing to  diagnosis  (n  =  100).
Pairs  of  variables  Spearman
correlation
coefﬁcient
p-level
E  &  PF  −0.4039  <0.0001
E &  RP  −0.3498  0.0004
E &  RE  −0.4129  <0.0001
E &  MHV −0.3333 0.0007
E  &  MH −0.4034 <0.0001
E  &  SF −0.4240 <0.0001
E  &  BP  −0.2939  0.0030
E &  GH  −0.2511  0.0117
FU &  PF  −0.5529  <0.0001
FU &  RP  −0.3697  0.0002
FU &  RE −0.3766 0.0001
FU  &  MHV −0.2610 0.0087
FU  &  MH −0.3877 0.0001
FU  &  SF −0.3310 0.0008
FU  &  BP  −0.3313  0.0008
FU &  GH  −0.2868  0.0038
PH &  PF  −0.5289  0.0000
PH &  RP  −0.2512  0.0117
PH &  RE  −0.2502  0.0120
PH &  MHV  −0.1548  0.1241
PH &  MH  −0.2863  0.0039
PH &  SF  −0.2061  0.0397
PH &  BP  −0.2895  0.0035
PH &  GH  −0.1500  0.1363
Total  &  PF  −0.5830  <0.0001
Total  &  RP  −0.3948  <0.0001
Total  &  RE  −0.4242  <0.0001
Total  &  MHV  −0.3045  0.0021
Total  &  MH  −0.4484  <0.0001
Total  &  SF  −0.3894  <0.0001
Total  &  BP  −0.3531  0.0003
Total  &  GH  −0.2819  0.0045
DHI variables: E, emotional; FU, functional; PH, physical.
SF-36 variables: PF, Physical Functioning; RP, Role Physical; RE,
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RRole Emotional; MHV, Mental Health Vitality; MH, Mental Health;
SF, Social Functioning; BP, Bodily Pain; GH, General Health.
and  unsteadiness.14--16 For  example,  patients  with  Ménière’s
disease  typically  suffer  from  unpredictable  attacks  of  symp-
toms  and  have  a  high  comorbidity  of  anxiety  and  depression
disorders,  and  as  a  result,  frequently  develop  avoidance
behavior  that  can  lead  to  limitations  in  their  participation.
HRQOL  measurement  varies  among  individuals  because
it  is  a  dynamic  construct  containing  continuous  interactions
between  the  patients  and  their  environment,  and  includes
physical,  mental  and  social  aspects.17,18 Consequently,  it  is
appropriate  to  examine  the  interaction  between  the  dis-
eases,  the  changes  occurring  in  the  life  of  the  individual,
the  received  and  perceived  social  contribution  and  the  stage
of  life  at  which  the  pathology  takes  place.  Most  studies  on
BPPV  report  a  good  efﬁcacy  of  BPPV  treatment  within  ﬁrst
week,  but  Obermann  et  al.  pointed  out  very  good  results
after  2  years  follow-up.5 In  a  study  involving  25  patients
with  dizziness  and  diagnostic  suspicion  of  peripheral  vesti-
bular  syndrome,  Gananc¸a et  al.19 showed  that  patients  with
1 PRESS
7
hronic  dizziness  had  a  worse  quality  of  life  in  terms  of  phys-
cal,  functional  and  emotional  aspects  of  their  lives  seen  on
he  Brazilian  DHI.
Our  results  showed  better  responses  at  one  month  with
ny  statistical  signiﬁcant  difference  between  7  days  and  14
ays.
Evaluation  of  quality  of  life  can  be  used  in  daily  practices
o  measure  contribution  of  clinical  handling  to  diminish  the
mpact  of  chronic  diseases  to  daily  routine  of  patients.
Our  study  has  some  limitations.  First,  the  small  num-
er  of  patients  could  not  offer  a  strong  conclusion.  Second,
he  selection  bias  (older  women,  exclusion  of  very  lightly
ffected  cases  that  were  addressed  to  the  general  practi-
ioners)  may  have  an  important  inﬂuence  on  the  results.
onclusion
he  DHI  and  the  SF-36  are  useful,  proved  practical  and  valid
nstruments  for  assessing  the  impact  of  dizziness  on  the  qual-
ty  of  life  of  patients  with  unilateral  peripheral  vestibular
isorders.  The  relationship  between  disability  and  HRQoL
ccording  to  diagnostics  type  pointed  out  a  moderate  corre-
ation  with  the  total  scores  of  both  instruments  before  and
fter  vestibular  treatment.
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